Recently stock market analysts have updated their consensus ratings on shares of Ambev S.A. (NYSE:ABEV). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/05/2016 – Ambev S.A. was downgraded to “neutral” by analysts at JP Morgan.

07/14/2015 – Ambev S.A. had its “equal weight” rating reiterated by analysts at Barclays.

05/01/2015 – Ambev S.A. had its “sell” rating reiterated by analysts at Zacks.

02/26/2015 – Ambev S.A. was downgraded to “neutral” by analysts at Mirabaud.

01/29/2015 – Ambev S.A. was upgraded to “buy” by analysts at Citigroup.

12/17/2014 – Ambev S.A. had its “overweight” rating reiterated by analysts at Morgan Stanley. They now have a USD 7.2 price target on the stock.

10/29/2014 – Ambev S.A. was upgraded to “buy” by analysts at Goldman Sachs.

09/23/2014 – Ambev S.A. had its “positive” rating reiterated by analysts at Bank of America Merrill Lynch.

06/10/2014 – Ambev S.A. was downgraded to “neutral” by analysts at Credit Suisse.

Ambev S.A. has a 50 day moving average of 5.28 and a 200 day moving average of 4.83. The stock’s market capitalization is 83.60B, it has a 52-week low of 3.86 and a 52-week high of 6.63.

The share price of the company (NYSE:ABEV) was down -0.37%, with a high of 5.38during the day and the volume of Ambev S.A. shares traded was 19915313.

View other investors thoughts on Ambev S.A. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.